Roche to acquire InterMune for $8.3bn
Swiss drugmaker Roche has signed a definitive merger agreement to acquire InterMune for around $8.3bn. As part of the all-cash ...
Swiss drugmaker Roche has signed a definitive merger agreement to acquire InterMune for around $8.3bn. As part of the all-cash ...
Germany-based Boehringer Ingelheim has enrolled the first patients in its new RE-DUAL PCI international phase III study to evaluate dabigatran ...
Brussels-based biopharmaceutical company Union Chimique Belge (UCB) broke ground for a new biotechnology pilot facility in Belgium in June 2010. ...
Vivalis opened a new R&D facility in Saint-Herblain, Nantes, France on 28 June 2010. The facility, located adjacent to its ...
Roche Mustahzarlari has completed the construction of their pharmaceutical facility at Gebze, close to Istanbul, Turkey. The new drugs manufacturing ...
Quintiles, a US-based biopharmaceutical services company, inaugurated its new research facility in London on 8 March 2010. Known as the ...
Novo Nordisk is upgrading the insulin production plant at its facility in Chartres, Eure-et-Loir region, France. The Danish company is ...
India-based contract manufacturer Kemwell launched a new solid and semi-solid pharmaceutical manufacturing facility in Sweden on 18 May 2010. Located ...
Mirapex (Pramipexole) is a medication indicated for Parkinson's disease (PD). Developed by Boehringer Ingelheim, Mirapex was approved by the US ...
Selincro (nalmefene) is an injected drug for the treatment of alcohol dependence. The drug was originally developed by Key Pharmaceuticals ...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.